BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19749289)

  • 41. Designing dual-targeting siRNA duplexes having two active strands that combine siRNA and microRNA-like targeting.
    Sætrom P
    Methods Mol Biol; 2013; 942():169-77. PubMed ID: 23027051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linear polyethylenimine as a tool for comparative studies of antisense and short double-stranded RNA oligonucleotides.
    Bologna JC; Dorn G; Natt F; Weiler J
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1729-31. PubMed ID: 14565506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
    Gong W; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stability of 3' double nucleotide overhangs that model the 3' ends of siRNA.
    O'Toole AS; Miller S; Serra MJ
    RNA; 2005 Apr; 11(4):512-6. PubMed ID: 15769878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and characterization of novel (S)-5'-C-aminopropyl-2'-fluorouridine modified oligonucleotides as therapeutic siRNAs.
    Sato H; Chandela A; Ueno Y
    Bioorg Med Chem; 2023 May; 87():117317. PubMed ID: 37196425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and characterization of small circular double-stranded RNAs.
    Abe N; Abe H; Ohshiro T; Nakashima Y; Maeda M; Ito Y
    Chem Commun (Camb); 2011 Feb; 47(7):2125-7. PubMed ID: 21180718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus.
    Brzezinska J; D'Onofrio J; Buff MC; Hean J; Ely A; Marimani M; Arbuthnot P; Engels JW
    Bioorg Med Chem; 2012 Feb; 20(4):1594-606. PubMed ID: 22264759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and gene silencing properties of siRNAs containing terminal amide linkages.
    Gaglione M; Mercurio ME; Potenza N; Mosca N; Russo A; Novellino E; Cosconati S; Messere A
    Biomed Res Int; 2014; 2014():901617. PubMed ID: 24791003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Silencing activity of 2'-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexes.
    Petrova NS; Meschaninova MI; Venyaminova AG; Zenkova MA; Vlassov VV; Chernolovskaya EL
    FEBS Lett; 2011 Jul; 585(14):2352-6. PubMed ID: 21704032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amides are excellent mimics of phosphate internucleoside linkages and are well tolerated in short interfering RNAs.
    Mutisya D; Selvam C; Lunstad BD; Pallan PS; Haas A; Leake D; Egli M; Rozners E
    Nucleic Acids Res; 2014 Jun; 42(10):6542-51. PubMed ID: 24813446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemical modification of siRNA.
    Deleavey GF; Watts JK; Damha MJ
    Curr Protoc Nucleic Acid Chem; 2009 Dec; Chapter 16():Unit 16.3. PubMed ID: 20013783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Artificial cationic peptides that increase nuclease resistance of siRNA without disturbing RNAi activity.
    Maeda Y; Iwata Hara R; Nishina K; Yoshida-Tanaka K; Sakamoto T; Yokota T; Wada T
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(5):338-348. PubMed ID: 30663497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and properties of double-stranded RNA-bindable oligodiaminogalactose derivatives conjugated with vitamin E.
    Iwata R; Nishina K; Yokota T; Wada T
    Bioorg Med Chem; 2014 Feb; 22(4):1394-403. PubMed ID: 24462177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipophilic 2'-O-Acetal Ester RNAs: Synthesis, Thermal Duplex Stability, Nuclease Resistance, Cellular Uptake, and siRNA Activity after Spontaneous Naked Delivery.
    Biscans A; Bertrand JR; Dubois J; Rüger J; Vasseur JJ; Sczakiel G; Dupouy C; Debart F
    Chembiochem; 2016 Nov; 17(21):2054-2062. PubMed ID: 27569765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variations of the 3' protruding ends in synthetic short interfering RNA (siRNA) tested by microinjection in Drosophila embryos.
    Boutla A; Delidakis C; Livadaras I; Tabler M
    Oligonucleotides; 2003; 13(5):295-301. PubMed ID: 15000820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An artificial cationic oligosaccharide combined with phosphorothioate linkages strongly improves siRNA stability.
    Irie A; Sato K; Hara RI; Wada T; Shibasaki F
    Sci Rep; 2020 Sep; 10(1):14845. PubMed ID: 32908235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of oligonucleotides with glucosamine at the 3'-position and evaluation of their biological activity.
    Luo X; Sugiura T; Nakashima R; Kitamura Y; Kitade Y
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4157-61. PubMed ID: 23743279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.
    Sano M; Sierant M; Miyagishi M; Nakanishi M; Takagi Y; Sutou S
    Nucleic Acids Res; 2008 Oct; 36(18):5812-21. PubMed ID: 18782830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-D-ribofuranose in their 3'-overhang region.
    Taniho K; Nakashima R; Kandeel M; Kitamura Y; Kitade Y
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2518-21. PubMed ID: 22377516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring directional invasion of serum nuclease into siRNA duplexes by asymmetrical terminal modifications.
    Huang Y; Ma Y; Guo Y; Zou L; Jin H; Zhong L; Wu Y; Zhang L; Yang Z
    ChemMedChem; 2014 Sep; 9(9):2111-9. PubMed ID: 25044832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.